Facilitators and barriers to participation of patients with treatment resistant depression in a randomised controlled trial of two forms of personalised magnetic resonance imaging targeted transcranial magnetic stimulation (the BRIGhTMIND trial)
(2025)
Journal Article
Boutry, C., Webster, L., Thomson, L., Harding, D., Reid, I., Bates, P., Gledhill, J., Mcnaughton, R., Eastham, J., Ooi, J., Willis, A., Marner, S., & Morriss, R. (2025). Facilitators and barriers to participation of patients with treatment resistant depression in a randomised controlled trial of two forms of personalised magnetic resonance imaging targeted transcranial magnetic stimulation (the BRIGhTMIND trial). BMC Psychiatry, 25, Article 728. https://doi.org/10.1186/s12888-025-06893-2
Background
Magnetic resonance imaging (MRI) can personalise the site of transcranial magnetic stimulation (TMS) delivered as a course of 20 sessions for treatment-resistant depression (TRD). Facilitators and barriers to a randomised controlled trial...
Read More about Facilitators and barriers to participation of patients with treatment resistant depression in a randomised controlled trial of two forms of personalised magnetic resonance imaging targeted transcranial magnetic stimulation (the BRIGhTMIND trial).